1. 1. PREFACE
1.1. Scope of the Report
1.1. Research Methodology
1.2. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Overview
3.2. Medication Adherence and its Measurement
3.3. Medication Non-Adherence and its Types
3.3.1. Factors Contributing to Non-Adherence
3.3.2. Impact of Non-Adherence on Health of Patients and Healthcare Industry
3.4. Improving Medication Adherence
3.4.1. Traditional Solutions to Medication Adherence
3.4.2. Modern Interventions to Medication Adherence
3.4.2.1. Connected Devices
3.4.2.2. Mobile Applications
3.4.2.3. Gamification
3.4.2.4. Compliance Packaging
3.5. Key Initiatives to Improve Medication Adherence

4. SMART DRUG DELIVERY DEVICES: CURRENT MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Smart Drug Delivery Devices: Overall Market Landscape
4.2.1. Distribution by Year of Establishment of Developers
4.2.2. Distribution by Geographical Location of Developers
4.2.3. Distribution by Size of Developers
4.2.4. Distribution by Type of Devices
4.2.5. Distribution by Mode of Drug Delivery
4.2.6. Distribution by Key Device Specifications
4.2.6.1. Audio / Visual Reminders
4.2.6.2. Connectivity (USB, Bluetooth, or Cellular)
4.2.6.3. Companion Mobile Application
4.2.6.4. Companion Web Portal
4.2.6.5. Data Storage / Cloud Platform
4.2.6.6. Rechargeable Battery / Battery Backup
4.2.7. Key Players
4.2.8. Smart Inhalers
4.2.8.1. Distribution by Year of Establishment of Developers
4.2.8.2. Distribution by Geographical Location of Developers
4.2.8.3. Distribution by Size of Developers
4.2.8.4. Distribution by Key Device Specifications
4.2.9. Smart Injectors
4.2.9.1. Distribution by Year of Establishment of Developers
4.2.9.2. Distribution by Geographical Location of Developers
4.2.9.3. Distribution by Size of Developers
4.2.9.4. Distribution by Key Device Specifications
4.2.10. Smart Wearable Injectors
4.2.10.1. Distribution by Year of Establishment of Developers
4.2.10.2. Distribution by Geographical Location of Developers
4.2.10.3. Distribution by Size of Developers
4.2.10.4. Distribution by Key Device Specifications
4.2.11. Smart Pills / Other Smart Devices
4.2.11.1. Distribution by Year of Establishment of Developers
4.2.11.2. Distribution by Geographical Location of Developers
4.2.11.3. Distribution by Size of Developers
4.2.11.4. Distribution by Key Device Specifications

5. SMART ACCESSORY DEVICES AND PACKAGING SYSTEMS: CURRENT MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Smart Accessory Devices: Overall Market Landscape
5.2.1. Distribution by Year of Establishment of Developers
5.2.2. Distribution by Geographical Location of Developers
5.2.3. Distribution by Size of Developer
5.2.4. Distribution by Type of Devices
5.2.5. Distribution by Key Device Specifications
5.2.5.1. Audio / Visual Reminders
5.2.5.2. Connectivity (USB, Bluetooth, Wi-Fi, or Cellular)
5.2.5.3. Companion Mobile Application
5.2.5.4. Companion Web Portal
5.2.5.5. Data Storage / Cloud Platform
5.2.5.6. Rechargeable Battery / Battery Backup
5.2.6. Key Players
5.2.7. Smart Medication Dispensers
5.2.7.1. Distribution by Year of Establishment of Developers
5.2.7.2. Distribution by Geographical Location of Developers
5.2.7.3. Distribution by Size of Developers
5.2.7.4. Distribution by Key Device Specifications
5.2.8. Smart Pill Bottles / Caps
5.2.8.1. Distribution by Year of Establishment of Developers
5.2.8.2. Distribution by Geographical Location of Developers
5.2.8.3. Distribution by Size of Developers
5.2.8.4. Distribution by Key Device Specifications
5.2.9. Smart Pill Boxes
5.2.9.1. Distribution by Year of Establishment of Developers
5.2.9.2. Distribution by Geographical Location of Developers
5.2.9.3. Distribution by Size of Developers
5.2.9.4. Distribution by Key Device Specifications
5.2.10. Smart Blister Packs
5.2.10.1. Distribution by Year of Establishment of Developers
5.2.10.2. Distribution by Geographical Location of Developers
5.2.10.3. Distribution by Size of Developers
5.2.10.4. Distribution by Key Device Specifications
5.2.11. Other Smart Devices
5.2.11.1. Distribution by Year of Establishment of Developers
5.2.11.2. Distribution by Geographical Location of Developers
5.2.11.3. Distribution by Size of Developers
5.2.11.4. Distribution by Key Device Specifications
5.3. Compliance Packaging Systems: Overall Market Landscape
5.3.1. Distribution by Geographical Location of Developers
5.3.2. Distribution by Size of Developers
5.3.3. Distribution by Type of Packaging System
5.3.4. Distribution by Key Specifications
5.3.4.1. Distribution by Number of Doses per Pack
5.3.4.2. Distribution by Availability of Other Key Features

6. REGULATORY LANDSCAPE FOR CONNECTED DRUG DELIVERY SYSTEMS
6.1. Chapter Overview
6.2. North America
6.2.1. Regulatory Approval of Combination Products in the US
6.2.1.1. Overview
6.2.1.2. Historical Background
6.2.1.3. Regulatory Bodies and their Role in Product Approval
6.2.2. Regulatory Approval of Combination Products in Canada
6.2.2.1. Overview
6.2.2.2. Regulatory Bodies and Their Role in Product Approval
6.3. Europe
6.3.1. Regulatory Approval of Combination Products in Europe
6.3.1.1. Overview
6.3.1.2. Regulatory Bodies and Their Role in Product Approval
6.4. Latin America
6.4.1. Regulatory Approval of Combination Products in Brazil
6.4.1.1. Overview
6.4.1.2. Regulatory Bodies and Their Role in Product Approval
6.4.2. Regulatory Approval of Combination Products in Mexico
6.4.2.1. Overview
6.4.2.2. Regulatory Bodies and Their Role in Product Approval
6.4.3. Regulations of Combination Products in Argentina
6.4.3.1. Overview
6.4.3.2. Regulatory Bodies and Their Role in Product Approval
6.5. Asia-Pacific
6.5.1. Regulatory Approval of Combination Products in Japan
6.5.1.1. Overview
6.5.1.2. Regulatory Bodies and Their Role in Product Approval
6.5.2. Regulation of Combination Products in South Korea
6.5.2.1. Overview
6.5.2.2. Regulatory Bodies and Their Role in Product Approval
6.5.3. Regulatory Approval of Combination Products in Australia
6.5.3.1. Overview
6.5.3.2. Regulatory Bodies and Their Role in Product Approval
6.5.4. Regulatory Approval of Combination Products in China
6.5.4.1. Overview
6.5.4.2. Regulatory Bodies and Their Role in Product Approval
6.5.5. Regulations of Combination Products in India
6.5.5.1. Overview
6.5.5.2. Regulatory Bodies and Their Role in Product Approval
6.6. Middle East
6.6.1. Regulation of Combination Products in Saudi Arabia
6.6.1.1. Overview
6.6.1.2. Regulatory Bodies and Their Role in Product Approval
6.6.2. Regulation of Combination Products in United Arab Emirates
6.6.2.1. Overview
6.6.2.2. Regulatory Bodies and Their Role in Product Approval
6.7. Connected Devices: Demonstrating Safety, Effectiveness and Performance
6.8. Connected Devices: Ensuring Security of Data Captured

7. DRUG DELIVERY DEVICES: COMPANY PROFILES
7.1. Chapter Overview
7.2. Adherium
7.2.1. Company Overview
7.2.2. Financial Information
7.2.3. Product Portfolio
7.2.4. Research Studies and Scientific Evidence
7.2.5. Recent Developments and Future Outlook
7.3. BIOCORP
7.3.1. Company Overview
7.3.2. Financial Information
7.3.3. Product Portfolio
7.3.4. Recent Developments and Future Outlook
7.4. nGageIT Digital Health
7.4.1. Company Overview
7.4.2. Product Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. Proteus Digital Health
7.5.1. Company Overview
7.5.2. Product Portfolio
7.5.3. Research Studies and Scientific Evidence
7.5.4. Recent Developments and Future Outlook
7.6. SOOIL Development
7.6.1. Company Overview
7.6.2. Product Portfolio
7.6.3. Recent Developments and Future Outlook
7.7. Ypsomed
7.7.1. Company Overview
7.7.2. Financial Information
7.7.3. Product Portfolio
7.7.4. Recent Developments and Future Outlook

8. ACCESSORY DEVICES: COMPANY PROFILES
8.1. Chapter Overview
8.2. AARDEX Group
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. Information Mediary
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Recent Developments and Future Outlook
8.4. MedMinder Systems
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. Philips
8.5.1. Company Overview
8.5.2. Financial Information
8.5.3. Product Portfolio
8.5.4. Research Studies and Scientific Evidence
8.5.5. Recent Developments and Future Outlook
8.6. Tinylogics
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Recent Developments and Future Outlook
8.7. Vaica
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Research Studies and Scientific Evidence
8.7.4. Recent Developments and Future Outlook

9. CASE STUDIES
9.1. Chapter Overview
9.2. Case Study I: Diabetes
9.2.1. Disease Description
9.2.2. Disease Statistics
9.2.3. Economic Burden due to Non-Adherence
9.2.4. Evolution of Drug Delivery / Connected Devices for Improving Adherence
9.3. Case Study II: Asthma
9.3.1. Disease Overview
9.3.2. Disease Statistics
9.3.3. Economic Burden due to Non-Adherence
9.3.4. Evolution of Drug Delivery / Connected Devices for Improving Adherence
9.4. Case Study III: Rheumatoid Arthritis
9.4.1. Disease Overview
9.4.2. Disease Statistics
9.4.3. Economic Burden due to Non-Adherence
9.4.4. Evolution of Drug Delivery / Connected Devices for Improving Adherence

10. PRODUCT COMPETITIVENESS ANALYSIS
10.1. Chapter Overview
10.2. Methodology
10.2.1. Key Parameters and Methodology
10.3. Overall Product Competitiveness Analysis
10.3.1. Product Competitiveness Analysis for Smart Medication Dispensers
10.3.2. Product Competitiveness Analysis for Smart Pill Packaging Systems
10.3.3. Product Competitiveness Analysis for Smart Inhalers
10.3.4. Product Competitiveness Analysis for Smart Injectors
10.3.5. Product Competitiveness Analysis for Smart Wearable Injectors

11. FUNDING AND INVESTMENT ANALYSIS
11.1. Chapter Overview
11.2. Types of Funding
11.3. Drug Adherence Enhancement Market: Funding and Investment Analysis
11.3.1. Analysis by Number of Instances
11.3.2. Analysis by Amount Invested
11.3.3. Analysis by Type of Funding
11.3.4. Analysis by Number of Funding Instances and Amount Invested in Different Types of Devices
11.3.5. Most Active Players
11.3.6. Most Active Investors
11.4. Concluding Remarks

12. PARTNERSHIPS AND COLLABORATIONS
12.1. Chapter Overview
12.2. Partnership Models
12.3. Drug Adherence Enhancement Market: List of Partnerships and Collaborations
12.3.1. Analysis by Year of Partnership
12.3.2. Analysis by Type of Partnership
12.3.3. Analysis by Geographical Activity
12.3.4. Most Active Players: Analysis by Number of Partnerships
12.3.5. Summary of Partnerships and Collaborations

13. MEDICATION ADHERENCE WITH MOBILE APPLICATIONS
13.1. Chapter Overview
13.2. The Increasing Trend of Mobile Applications in Healthcare Industry
13.3. USFDA Regulations for Mobile Medical Applications
13.4. List of Mobile Applications for Improving Medication Adherence
13.5. Medication Adherence with Mobile Applications: Clinical Research Evidence
13.5.1. Distribution by Therapeutic Area

14. MARKET FORECAST
14.1. Chapter Overview
14.2. Forecast Methodology and Key Assumptions
14.3. Global Smart Drug Delivery Devices Market
14.3.1. Global Smart Drug Delivery Devices Market, 2018-2030 (By Value)
14.3.2. Global Smart Drug Delivery Devices Market, 2018-2030 (By Volume)
14.4. Global Smart Drug Delivery Devices Market: Distribution by Geography, 2018-2030 (By Value)
14.4.1. Smart Drug Delivery Devices Market in North America, 2018-2030 (By Value)
14.4.2. Smart Drug delivery Devices Market in Europe, 2018-2030 (By Value)
14.4.3. Smart Drug Delivery Devices Market in Asia-Pacific, 2018-2030 (By Value)
14.4.4. Smart Drug Delivery Devices Market in Rest of the World, 2018-2030 (By Value)
14.5. Global Smart Drug Delivery Devices Market: Distribution by Geography, 2018-2030 (By Volume)
14.5.1. Smart Drug Delivery Devices Market in North America, 2018-2030 (By Volume)
14.5.2. Smart Drug delivery Devices Market in Europe, 2018-2030 (By Volume)
14.5.3. Smart Drug Delivery Devices Market in Asia-Pacific, 2018-2030 (By Volume)
14.5.4. Smart Drug Delivery Devices Market in Rest of the World, 2018-2030 (By Volume)
14.6. Global Smart Drug Delivery Devices Market: Distribution by Type of Product and Geography (By Value)
14.6.1. Smart Drug Delivery Devices Market: Smart Inhalers, 2018-2030 (By Value)
14.6.1.1. Smart Inhalers Market in North America, 2018-2030 (By Value)
14.6.1.2. Smart Inhalers Market in Europe, 2018-2030 (By Value)
14.6.1.3. Smart Inhalers Market in Asia-Pacific, 2018-2030 (By Value)
14.6.1.4. Smart Inhalers Market in Rest of the World, 2018-2030 (By Value)
14.6.2. Smart Drug Delivery Devices Market: Smart Injectors, 2018-2030 (By Value)
14.6.2.1. Smart Injectors Market in North America, 2018-2030 (By Value)
14.6.2.2. Smart Injectors Market in Europe, 2018-2030 (By Value)
14.6.2.3. Smart Injectors Market in Asia-Pacific, 2018-2030 (By Value)
14.6.2.4. Smart Injectors Market in Rest of the World, 2018-2030 (By Value)
14.6.3. Smart Drug Delivery Devices Market: Smart Pills, 2018-2030 (By Value)
14.6.3.1. Smart Pills Market in North America, 2018-2030 (By Value)
14.6.3.2. Smart Pills Market in Europe, 2018-2030 (By Value)
14.6.3.3. Smart Pills Market in Asia-Pacific, 2018-2030 (By Value)
14.6.3.4. Smart Pills Market in Rest of the World, 2018-2030 (By Value)
14.7. Global Smart Drug Delivery Devices Market: Distribution by Type of Product and Geography (By Volume)
14.7.1. Smart Drug Delivery Devices Market: Smart Inhalers, 2018-2030 (By Volume)
14.7.1.1. Smart Inhalers Market in North America, 2018-2030 (By Volume)
14.7.1.2. Smart Inhalers Market in Europe, 2018-2030 (By Volume)
14.7.1.3. Smart Inhalers Market in Asia-Pacific, 2018-2030 (By Volume)
14.7.1.4. Smart Inhalers Market in Rest of the World, 2018-2030 (By Volume)
14.7.2. Smart Drug Delivery Devices Market: Smart Injectors, 2018-2030 (By Volume)
14.7.2.1. Smart Injectors Market in North America, 2018-2030 (By Volume)
14.7.2.2. Smart Injectors Market in Europe, 2018-2030 (By Volume)
14.7.2.3. Smart Injectors Market in Asia-Pacific, 2018-2030 (By Volume)
14.7.2.4. Smart Injectors Market in Rest of the World, 2018-2030 (By Volume)
14.7.3. Smart Drug Delivery Devices Market: Smart Pills, 2018-2030 (By Volume)
14.7.3.1. Smart Pills Market in North America, 2018-2030 (By Volume)
14.7.3.2. Smart Pills Market in Europe, 2018-2030 (By Volume)
14.7.3.3. Smart Pills Market in Asia-Pacific, 2018-2030 (By Volume)
14.7.3.4. Smart Pills Market in Rest of the World, 2018-2030 (By Value)
14.8. Global Smart Drug Delivery Devices Market: Distribution by Therapeutic Area and Geography (By Value)
14.8.1. Smart Drug Delivery Devices Market for Metabolic Disorders (By Value)
14.8.1.1. Smart Drug Delivery Devices Market for Metabolic Disorders in North America, 2018-2030 (By Value)
14.8.1.2. Smart Drug Delivery Devices Market for Metabolic Disorders in Europe, 2018-2030 (By Value)
14.8.1.3. Smart Drug Delivery Devices Market for Metabolic Disorders in Asia-Pacific, 2018-2030 (By Value)
14.8.1.4. Smart Drug Delivery Devices Market for Metabolic Disorders in Rest of the World, 2018-2030 (By Value)
14.8.2. Smart Drug Delivery Devices Market for Cardiovascular Disorders (By Value)
14.8.2.1. Smart Drug Delivery Devices Market for Cardiovascular Disorders in North America, 2018-2030 (By Value)
14.8.2.2. Smart Drug Delivery Devices Market for Cardiovascular Disorders in Europe, 2018-2030 (By Value)
14.8.2.3. Smart Drug Delivery Devices Market for Cardiovascular Disorders in Asia-Pacific, 2018-2030 (By Value)
14.8.2.4. Smart Drug Delivery Devices Market for Cardiovascular Disorders in Rest of the World, 2018-2030 (By Value)
14.8.3. Smart Drug Delivery Devices Market for Neurological Disorders (By Value)
14.8.3.1. Smart Drug Delivery Devices Market for Neurological Disorders in North America, 2018-2030 (By Value)
14.8.3.2. Smart Drug Delivery Devices Market for Neurological Disorders in Europe, 2018-2030 (By Value)
14.8.3.3. Smart Drug Delivery Devices Market for Neurological Disorders in Asia-Pacific, 2018-2030 (By Value)
14.8.3.4. Smart Drug Delivery Devices Market for Neurological Disorders in Rest of the World, 2018-2030 (By Value)
14.8.4. Smart Drug Delivery Devices Market for Respiratory Disorders (By Value)
14.8.4.1. Smart Drug Delivery Devices Market for Respiratory Disorders in North America, 2018-2030 (By Value)
14.8.4.2. Smart Drug Delivery Devices Market for Respiratory Disorders in Europe, 2018-2030 (By Value)
14.8.4.3. Smart Drug Delivery Devices Market for Respiratory Disorders in Asia-Pacific, 2018-2030 (By Value)
14.8.4.4. Smart Drug Delivery Devices Market for Respiratory Disorders in Rest of The World, 2018-2030 (By Value)
14.8.5. Smart Drug Delivery Devices Market for Other Disorders (By Value)
14.8.5.1. Smart Drug Delivery Devices Market for Other Disorders in North America, 2018-2030 (By Value)
14.8.5.2. Smart Drug Delivery Devices Market for Other Disorders in Europe, 2018-2030 (By Value)
14.8.5.3. Smart Drug Delivery Devices Market for Other Disorders in Asia-Pacific, 2018-2030 (By Value)
14.8.5.4. Smart Drug Delivery Devices Market for Other Disorders in Rest of the World, 2018-2030 (By Value)
14.9. Global Smart Drug Delivery Devices Market: Distribution by Therapeutic Area and Geography (By Volume)
14.9.1. Smart Drug Delivery Devices Market for Metabolic Disorders (By Volume)
14.9.1.1. Smart Drug Delivery Devices Market for Metabolic Disorders in North America, 2018-2030 (By Volume)
14.9.1.2. Smart Drug Delivery Devices Market for Metabolic Disorders in Europe, 2018-2030 (By Volume)
14.9.1.3. Smart Drug Delivery Devices Market for Metabolic Disorders in Asia-Pacific, 2018-2030 (By Volume)
14.9.1.4. Smart Drug Delivery Devices Market for Metabolic Disorders in Rest of the World, 2018-2030 (By Volume)
14.9.2. Smart Drug Delivery Devices Market for Cardiovascular Disorders (By Volume)
14.9.2.1. Smart Drug Delivery Devices Market for Cardiovascular Disorders in North America, 2018-2030 (By Volume)
14.9.2.2. Smart Drug Delivery Devices Market for Cardiovascular Disorders in Europe, 2018-2030 (By Volume)
14.9.2.3. Smart Drug Delivery Devices Market for Cardiovascular Disorders in Asia-Pacific, 2018-2030 (By Volume)
14.9.2.4. Smart Drug Delivery Devices Market for Cardiovascular Disorders in Rest of the World, 2018-2030 (By Volume)
14.9.3. Smart Drug Delivery Devices Market for Neurological Disorders (By Volume)
14.9.3.1. Smart Drug Delivery Devices Market for Neurological Disorders in North America, 2018-2030 (By Volume)
14.9.3.2. Smart Drug Delivery Devices Market for Neurological Disorders in Europe, 2018-2030 (By Volume)
14.9.3.3. Smart Drug Delivery Devices Market for Neurological Disorders in Asia-Pacific, 2018-2030 (By Volume)
14.9.3.4. Smart Drug Delivery Devices Market for Neurological Disorders in Rest of the World, 2018-2030 (By Volume)
14.9.4. Smart Drug Delivery Devices Market for Respiratory Disorders (By Volume)
14.9.4.1. Smart Drug Delivery Devices Market for Respiratory Disorders in North America, 2018-2030 (By Volume)
14.9.4.2. Smart Drug Delivery Devices Market for Respiratory Disorders in Europe, 2018-2030 (By Volume)
14.9.4.3. Smart Drug Delivery Devices Market for Respiratory Disorders in Asia-Pacific, 2018-2030 (By Volume)
14.9.4.4. Smart Drug Delivery Devices Market for Respiratory Disorders in Rest of The World, 2018-2030 (By Volume)
14.9.5. Smart Drug Delivery Devices Market for Other Disorders (By Volume)
14.9.5.1. Smart Drug Delivery Devices Market for Other Disorders in North America, 2018-2030 (By Volume)
14.9.5.2. Smart Drug Delivery Devices Market for Other Disorders in Europe, 2018-2030 (By Volume)
14.9.5.3. Smart Drug Delivery Devices Market for Other Disorders in Asia-Pacific, 2018-2030 (By Volume)
14.9.5.4. Smart Drug Delivery Devices Market for Other Disorders in Rest of the World, 2018-2030 (By Volume)
14.10. Global Smart Drug Delivery Devices Market: Distribution by Route of Drug Administration and Geography (By Value)
14.10.1. Smart Drug Delivery Devices Market for Products Intended for Oral Medications, 2018-2030 (By Value)
14.10.1.1. Smart Drug Delivery Devices Market for Products Intended for Oral Medications in North America, 2018-2030 (By Value)
14.10.1.2. Smart Drug Delivery Devices Market for Products Intended for Oral Medications in Europe, 2018-2030 (By Value)
14.10.1.3. Smart Drug Delivery Devices Market for Products Intended for Oral Medications in Asia-Pacific, 2018-2030 (By Value)
14.10.1.4. Smart Drug Delivery Devices Market for Products Intended for Oral Medications in Rest of the World, 2018-2030 (By Value)
14.10.2. Smart Drug Delivery Devices Market for Products Intended for Injectables, 2018-2030 (By Value)
14.10.2.1. Smart Drug Delivery Devices Market for Products Intended for Injectables in North America, 2018-2030 (By Value)
14.10.2.2. Smart Drug Delivery Devices Market for Products Intended for Injectables in Europe, 2018-2030 (By Value)
14.10.2.3. Smart Drug Delivery Devices Market for Products Intended for Injectables in Asia-Pacific, 2018-2030 (By Value)
14.10.2.4. Smart Drug Delivery Devices Market for Products Intended for Injectables in Rest of the World, 2018-2030 (By Value)
14.10.3. Smart Drug Delivery Devices Market for Products Intended for Inhalable Medications, 2018-2030 (By Value)
14.10.3.1. Smart Drug Delivery Devices Market for Products Intended for Inhalable Medications in North America, 2018-2030 (By Value)
14.10.3.2. Smart Drug Delivery Devices Market for Products Intended for Inhalable Medications in Europe, 2018-2030 (By Value)
14.10.3.3. Smart Drug Delivery Devices Market for Products Intended for Inhalable Medications in Asia-Pacific, 2018-2030 (By Value)
14.10.3.4. Smart Drug Delivery Devices Market for Products Intended for Inhalable Medications in Rest of the World, 2018-2030 (By Value)
14.11. Global Smart Drug Delivery Devices Market: Distribution by Route of Drug Administration and Geography (By Volume)
14.11.1. Smart Drug Delivery Devices Market for Products Intended for Oral Medications, 2018-2030 (By Volume)
14.11.1.1. Smart Drug Delivery Devices Market for Products Intended for Oral Medications in North America, 2018-2030 (By Volume)
14.11.1.2. Smart Drug Delivery Devices Market for Products Intended for Oral Medications in Europe, 2018-2030 (By Volume)
14.11.1.3. Smart Drug Delivery Devices Market for Products Intended for Oral Medications in Asia-Pacific, 2018-2030 (By Volume)
14.11.1.4. Smart Drug Delivery Devices Market for Products Intended for Oral Medications in Rest of the World, 2018-2030 (By Volume)
14.11.2. Smart Drug Delivery Devices Market for Products Intended for Injectables, 2018-2030 (By Volume)
14.11.2.1. Smart Drug Delivery Devices Market for Products Intended for Injectables in North America, 2018-2030 (By Volume)
14.11.2.2. Smart Drug Delivery Devices Market for Products Intended for Injectables in Europe, 2018-2030 (By Volume)
14.11.2.3. Smart Drug Delivery Devices Market for Products Intended for Injectables in Asia-Pacific, 2018-2030 (By Volume)
14.11.2.4. Smart Drug Delivery Devices Market for Products Intended for Injectables in Rest of the World, 2018-2030 (By Volume)
14.11.3. Smart Drug Delivery Devices Market for Products Intended for Inhalable Medications, 2018-2030 (By Volume)
14.11.3.1. Smart Drug Delivery Devices Market for Products Intended for Inhalable Medications in North America, 2018-2030 (By Volume)
14.11.3.2. Smart Drug Delivery Devices Market for Products Intended for Inhalable Medications in Europe, 2018-2030 (By Volume)
14.11.3.3. Smart Drug Delivery Devices Market for Products Intended for Inhalable Medications in Asia-Pacific, 2018-2030 (By Volume)
14.11.3.4. Smart Drug Delivery Devices Market for Products Intended for Inhalable Medications in Rest of the World, 2018-2030 (By Volume)
14.12. Global Smart Accessory Devices Market
14.12.1. Global Smart Accessory Devices Market, 2018-2030 (By Value)
14.12.2. Global Smart Accessory Devices Market, 2018-2030 (By Volume)
14.13. Global Smart Accessory Devices Market: Distribution by Geography, 2018-2030 (By Value)
14.13.1. Smart Accessory Devices Market in North America, 2018-2030 (By Value)
14.13.2. Smart Accessory Devices Market in Europe, 2018-2030 (By Value)
14.13.3. Smart Accessory Devices Market in Asia-Pacific, 2018-2030 (By Value)
14.13.4. Smart Accessory Devices Market in Rest of the World, 2018-2030 (By Value)
14.14. Global Smart Accessory Devices Market: Distribution by Geography, 2018-2030 (By Volume)
14.14.1. Smart Accessory Devices Market in North America, 2018-2030 (By Volume)
14.14.2. Smart Accessory Devices Market in Europe, 2018-2030 (By Volume)
14.14.3. Smart Accessory Devices Market in Asia-Pacific, 2018-2030 (By Volume)
14.14.4. Smart Accessory Devices Market in Rest of the World, 2018-2030 (By Volume)
14.15. Global Smart Accessory Devices Market: Distribution by Type of Product and Geography (By Value)
14.15.1. Smart Accessory Devices Market: Smart Medication Dispensers, 2018-2030 (By Value)
14.15.1.1. Smart Medication Dispensers Market in North America, 2018-2030 (By Value)
14.15.1.2. Smart Medication Dispensers Market in Europe, 2018-2030 (By Value)
14.15.1.3. Smart Medication Dispensers Market in Asia-Pacific, 2018-2030 (By Value)
14.15.1.4. Smart Medication Dispensers Market in Rest of the World, 2018-2030 (By Value)
14.15.2. Smart Accessory Devices Market: Smart Blister Packs, 2018-2030 (By Value)
14.15.2.1. Smart Blister Packs Market in North America, 2018-2030 (By Value)
14.15.2.2. Smart Blister Packs Market in Europe, 2018-2030 (By Value)
14.15.2.3. Smart Blister Packs Market in Asia-Pacific, 2018-2030 (By Value)
14.15.2.4. Smart Blister Packs Market in Rest of the World, 2018-2030 (By Value)
14.15.3. Smart Accessory Devices Market: Smart Pill Bottles / Caps, 2018-2030 (By Value)
14.15.3.1. Smart Pill Bottles / Caps Market in North America, 2018-2030 (By Value)
14.15.3.2. Smart Pill Bottles / Caps Market in Europe, 2018-2030 (By Value)
14.15.3.3. Smart Pill Bottles / Caps Market in Asia-Pacific, 2018-2030 (By Value)
14.15.3.4. Smart Pill Bottles / Caps Market in Rest of the World, 2018-2030 (By Value)
14.16. Global Smart Accessory Devices Market: Distribution by Type of Product and Geography (By Volume)
14.16.1. Smart Accessory Devices Market: Smart Medication Dispensers, 2018-2030 (By Volume)
14.16.1.1. Smart Medication Dispensers Market in North America, 2018-2030 (By Volume)
14.16.1.2. Smart Medication Dispensers Market in Europe, 2018-2030 (By Volume)
14.16.1.3. Smart Medication Dispensers Market in Asia-Pacific, 2018-2030 (By Volume)
14.16.1.4. Smart Medication Dispensers Market in Rest of the World, 2018-2030 (By Volume)
14.16.2. Smart Accessory Devices Market: Smart Blister Packs, 2018-2030 (By Volume)
14.16.2.1. Smart Blister Packs Market in North America, 2018-2030 (By Volume)
14.16.2.2. Smart Blister Packs Market in Europe, 2018-2030 (By Volume)
14.16.2.3. Smart Blister Packs Market in Asia-Pacific, 2018-2030 (By Volume)
14.16.2.4. Smart Blister Packs Market in Rest of the World, 2018-2030 (By Volume)
14.16.3. Smart Accessory Devices Market: Smart Pill Bottles / Caps, 2018-2030 (By Volume)
14.16.3.1. Smart Pill Bottles / Caps Market in North America, 2018-2030 (By Volume)
14.16.3.2. Smart Pill Bottles / Caps Market in Europe, 2018-2030 (By Volume)
14.16.3.3. Smart Pill Bottles / Caps Market in Asia-Pacific, 2018-2030 (By Volume)
14.16.3.4. Smart Pill Bottles / Caps Market in Rest of the World, 2018-2030 (By Value)
14.17. Global Smart Accessory Devices Market: Distribution by Therapeutic Area and Geography (By Value)
14.17.1. Smart Accessory Devices Market for Metabolic Disorders (By Value)
14.17.1.1. Smart Accessory Devices Market for Metabolic Disorders in North America, 2018-2030 (By Value)
14.17.1.2. Smart Accessory Devices Market for Metabolic Disorders in Europe, 2018-2030 (By Value)
14.17.1.3. Smart Accessory Devices Market for Metabolic Disorders in Asia-Pacific, 2018-2030 (By Value)
14.17.1.4. Smart Accessory Devices Market for Metabolic Disorders in Rest of the World, 2018-2030 (By Value)
14.17.2. Smart Accessory Devices Market for Cardiovascular Disorders (By Value)
14.17.2.1. Smart Accessory Devices Market for Cardiovascular Disorders in North America, 2018-2030 (By Value)
14.17.2.2. Smart Accessory Devices Market for Cardiovascular Disorders in Europe, 2018-2030 (By Value)
14.17.2.3. Smart Accessory Devices Market for Cardiovascular Disorders in Asia-Pacific, 2018-2030 (By Value)
14.17.2.4. Smart Accessory Devices Market for Cardiovascular Disorders in Rest of the World, 2018-2030 (By Value)
14.17.3. Smart Accessory Devices Market for Neurological Disorders (By Value)
14.17.3.1. Smart Accessory Devices Market for Neurological Disorders in North America, 2018-2030 (By Value)
14.17.3.2. Smart Accessory Devices Market for Neurological Disorders in Europe, 2018-2030 (By Value)
14.17.3.3. Smart Accessory Devices Market for Neurological Disorders in Asia-Pacific, 2018-2030 (By Value)
14.17.3.4. Smart Accessory Devices Market for Neurological Disorders in Rest of the World, 2018-2030 (By Value)
14.17.4. Smart Accessory Devices Market for Respiratory Disorders (By Value)
14.17.4.1. Smart Accessory Devices Market for Respiratory Disorders in North America, 2018-2030 (By Value)
14.17.4.2. Smart Accessory Devices Market for Respiratory Disorders in Europe, 2018-2030 (By Value)
14.17.4.3. Smart Accessory Devices Market for Respiratory Disorders in Asia-Pacific, 2018-2030 (By Value)
14.17.4.4. Smart Accessory Devices Market for Respiratory Disorders in Rest of The World, 2018-2030 (By Value)
14.17.5. Smart Accessory Devices Market for Other Disorders (By Value)
14.17.5.1. Smart Accessory Devices Market for Other Disorders in North America, 2018-2030 (By Value)
14.17.5.2. Smart Accessory Devices Market for Other Disorders in Europe, 2018-2030 (By Value)
14.17.5.3. Smart Accessory Devices Market for Other Disorders in Asia-Pacific, 2018-2030 (By Value)
14.17.5.4. Smart Accessory Devices Market for Other Disorders in Rest of the World, 2018-2030 (By Value)
14.18. Global Smart Accessory Devices Market: Distribution by Therapeutic Area and Geography (By Volume)
14.18.1. Smart Accessory Devices Market for Metabolic Disorders (By Volume)
14.18.1.1. Smart Accessory Devices Market for Metabolic Disorders in North America, 2018-2030 (By Volume)
14.18.1.2. Smart Accessory Devices Market for Metabolic Disorders in Europe, 2018-2030 (By Volume)
14.18.1.3. Smart Accessory Devices Market for Metabolic Disorders in Asia-Pacific, 2018-2030 (By Volume)
14.18.1.4. Smart Accessory Devices Market for Metabolic Disorders in Rest of the World, 2018-2030 (By Volume)
14.18.2. Smart Accessory Devices Market for Cardiovascular Disorders (By Volume)
14.18.2.1. Smart Accessory Devices Market for Cardiovascular Disorders in North America, 2018-2030 (By Volume)
14.18.2.2. Smart Accessory Devices Market for Cardiovascular Disorders in Europe, 2018-2030 (By Volume)
14.18.2.3. Smart Accessory Devices Market for Cardiovascular Disorders in Asia-Pacific, 2018-2030 (By Volume)
14.18.2.4. Smart Accessory Devices Market for Cardiovascular Disorders in Rest of the World, 2018-2030 (By Volume)
14.18.3. Smart Accessory Devices Market for Neurological Disorders (By Volume)
14.18.3.1. Smart Accessory Devices Market for Neurological Disorders in North America, 2018-2030 (By Volume)
14.18.3.2. Smart Accessory Devices Market for Neurological Disorders in Europe, 2018-2030 (By Volume)
14.18.3.3. Smart Accessory Devices Market for Neurological Disorders in Asia-Pacific, 2018-2030 (By Volume)
14.18.3.4. Smart Accessory Devices Market for Neurological Disorders in Rest of the World, 2018-2030 (By Volume)
14.18.4. Smart Accessory Devices Market for Respiratory Disorders (By Volume)
14.18.4.1. Smart Accessory Devices Market for Respiratory Disorders in North America, 2018-2030 (By Volume)
14.18.4.2. Smart Accessory Devices Market for Respiratory Disorders in Europe, 2018-2030 (By Volume)
14.18.4.3. Smart Accessory Devices Market for Respiratory Disorders in Asia-Pacific, 2018-2030 (By Volume)
14.18.4.4. Smart Accessory Devices Market for Respiratory Disorders in Rest of The World, 2018-2030 (By Volume)
14.18.5. Smart Accessory Devices Market for Other Disorders (By Volume)
14.18.5.1. Smart Accessory Devices Market for Other Disorders in North America, 2018-2030 (By Volume)

Please contact our Customer Support Center to get the complete Table of Contents